Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Basal and Bolus Insulin Distribution According to Treatment Modality: Data from SWEET Diabetes Registry

F. Evin, SR. Tittel, B. Piccini, R. Cardona-Hernandez, D. Mul, N. Sheanon, T. von dem Berge, V. Neuman, M. Tauschmann, D. Gökşen

. 2023 ; 2023 (-) : 8837506. [pub] 20230809

Jazyk angličtina

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25016464

BACKGROUND AND AIMS: The optimal basal and bolus insulin distribution in type 1 diabetes (T1D) is still controversial. Herein, we aimed to determine the variability of basal to total daily insulin dose according to treatment modality and diabetes technologies from the Better Control in Pediatric and Adolescent Diabetes: Working to Create Centers of Reference (SWEET) registry. Methods. The study cohort was generated by using the SWEET database. Patients with T1D for at least 2 years, aged between 2.5 and 18 years, with at least one clinic visit between June 2010 and June 2021, were included in the study. Four groups were composed according to treatment modality as follows: multiple daily injections (MDI) without continuous glucose monitoring (CGM); MDI with CGM; subcutaneous insulin infusion (CSII) without CGM; and CSII with CGM. Data of the participants were analyzed and compared for each treatment modality separately. RESULTS: A total of 38,956 children and adolescents were included in the study. Of the study sample, 48.6% were female, the median (range) age was 15.2 (11.9-17.2) years, and the median diabetes duration was 6.0 (3.8-9.0) years. The distribution of treatment modality was as follows: MDI without CGM, 32.9%; MDI with CGM, 18.0%; CSII without CGM, 11.7%; and CSII with CGM, 37.3%. In unadjusted data, regardless of treatment modality, all the analyses revealed a significant association between basal dose to total daily insulin dose (BD/TDD) with male gender, younger age group, and lower HbA1c, which were all related to a decreased ratio of BD/TDD (all p < 0.05). There was no association between BD/TDD and different diabetes technologies after the age, gender, and diabetes duration were adjusted. CONCLUSIONS: Herein, we showed that there was an association between lower proportions of basal to total insulin and lower hemoglobin A1c in a large cross-sectional cohort of children who had T1D. There was also an association between lower BD/TDD and younger age. There was no significant difference between BD/TDD ratios under different diabetes technologies (CGM and/or CSII).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25016464
003      
CZ-PrNML
005      
20250731092924.0
007      
ta
008      
250708e20230809xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2023/8837506 $2 doi
035    __
$a (PubMed)40303252
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a x
100    1_
$a Evin, Ferda $u Division of Pediatric Endocrinology, Department of Pediatrics, School of Medicine, Ege University, Izmir, Turkey $1 https://orcid.org/000000017169890X
245    10
$a Basal and Bolus Insulin Distribution According to Treatment Modality: Data from SWEET Diabetes Registry / $c F. Evin, SR. Tittel, B. Piccini, R. Cardona-Hernandez, D. Mul, N. Sheanon, T. von dem Berge, V. Neuman, M. Tauschmann, D. Gökşen
520    9_
$a BACKGROUND AND AIMS: The optimal basal and bolus insulin distribution in type 1 diabetes (T1D) is still controversial. Herein, we aimed to determine the variability of basal to total daily insulin dose according to treatment modality and diabetes technologies from the Better Control in Pediatric and Adolescent Diabetes: Working to Create Centers of Reference (SWEET) registry. Methods. The study cohort was generated by using the SWEET database. Patients with T1D for at least 2 years, aged between 2.5 and 18 years, with at least one clinic visit between June 2010 and June 2021, were included in the study. Four groups were composed according to treatment modality as follows: multiple daily injections (MDI) without continuous glucose monitoring (CGM); MDI with CGM; subcutaneous insulin infusion (CSII) without CGM; and CSII with CGM. Data of the participants were analyzed and compared for each treatment modality separately. RESULTS: A total of 38,956 children and adolescents were included in the study. Of the study sample, 48.6% were female, the median (range) age was 15.2 (11.9-17.2) years, and the median diabetes duration was 6.0 (3.8-9.0) years. The distribution of treatment modality was as follows: MDI without CGM, 32.9%; MDI with CGM, 18.0%; CSII without CGM, 11.7%; and CSII with CGM, 37.3%. In unadjusted data, regardless of treatment modality, all the analyses revealed a significant association between basal dose to total daily insulin dose (BD/TDD) with male gender, younger age group, and lower HbA1c, which were all related to a decreased ratio of BD/TDD (all p < 0.05). There was no association between BD/TDD and different diabetes technologies after the age, gender, and diabetes duration were adjusted. CONCLUSIONS: Herein, we showed that there was an association between lower proportions of basal to total insulin and lower hemoglobin A1c in a large cross-sectional cohort of children who had T1D. There was also an association between lower BD/TDD and younger age. There was no significant difference between BD/TDD ratios under different diabetes technologies (CGM and/or CSII).
650    _2
$a lidé $7 D006801
650    12
$a diabetes mellitus 1. typu $x farmakoterapie $x krev $7 D003922
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mladiství $7 D000293
650    _2
$a registrace $7 D012042
650    12
$a inzulin $x aplikace a dávkování $7 D007328
650    12
$a hypoglykemika $x aplikace a dávkování $7 D007004
650    _2
$a předškolní dítě $7 D002675
650    _2
$a inzulinové infuzní systémy $7 D007332
650    _2
$a krevní glukóza $x analýza $7 D001786
650    _2
$a selfmonitoring glykemie $7 D015190
650    _2
$a glykovaný hemoglobin $x analýza $7 D006442
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tittel, Sascha R $u Institute of Epidemiology and Medical Biometry, Central Institute for Biomedical Technology (ZIBMT), Ulm University, Ulm, Germany $u German Center for Diabetes Research (DZD), Munich, Neuherberg, Germany $1 https://orcid.org/0000000179136135
700    1_
$a Piccini, Barbara $u Diabetology Unit, Meyer University Children's Hospital IRCCS, Florence, Italy $1 https://orcid.org/0000000226848638
700    1_
$a Cardona-Hernandez, Roque $u Division of Pediatric Endocrinology, Hospital Sant Joan de Déu, Barcelona, Spain $1 https://orcid.org/0000000270671657
700    1_
$a Mul, Dick $u Diabeter, Center for Pediatric and Adult Diabetes Care and Research, Rotterdam, Netherlands $1 https://orcid.org/0000000180959155
700    1_
$a Sheanon, Nicole $u Division of Pediatric Endocrinology, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA $1 https://orcid.org/0000000313381052
700    1_
$a von dem Berge, Thekla $u Kinder und Jugendkrankenhaus AUF DER BULT, Diabetes Center for Children and Adolescents, Hannover, Germany $1 https://orcid.org/0000000326536359
700    1_
$a Neuman, Vit $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000217455285
700    1_
$a Tauschmann, Martin $u Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000223052490
700    1_
$a Gökşen, Damla $u Division of Pediatric Endocrinology, Department of Pediatrics, School of Medicine, Ege University, Izmir, Turkey $1 https://orcid.org/0000000161080591
773    0_
$w MED00181048 $t Pediatric diabetes $x 1399-5448 $g Roč. 2023 (20230809), s. 8837506
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40303252 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731092918 $b ABA008
999    __
$a ok $b bmc $g 2366953 $s 1253589
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 2023 $c - $d 8837506 $e 20230809 $i 1399-5448 $m Pediatric diabetes $n Pediatr Diabetes $x MED00181048
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Možnosti archivace